Wolverine Stack
Popular healing/repair stack pairing BPC-157 with TB-500 for soft-tissue and recovery support.
Concentration over time
| Date | TB-500 (Thymosin Beta-4) | BPC-157 |
|---|---|---|
| W1 | 0.00 | 0.00 |
| W2 | 0.00 | 0.12 |
| W3 | 0.00 | 0.59 |
| W4 | 0.00 | 0.05 |
| W5 | 0.00 | 0.23 |
| W6 | 0.00 | 1.01 |
| W7 | 0.00 | 0.09 |
| W8 | 0.00 | 0.42 |
| W6 | 0.00 | |
| W7 | 0.00 | |
| W7 | 0.00 | |
| W8 | 0.00 | |
| W9 | 0.00 |
Protocol summary
Wolverine Stack · 8 weeks starting Jul 20, 26
- BPC-157 — 500 mcg Every day, weeks 0–8
- TB-500 (Thymosin Beta-4) — 2.50 mg Every 7 days, weeks 0–8
Protocol overview
- Category
- peptide stack
- Duration
- 8 weeks
- Compounds
- 2
- Tags
- healing, recovery, bpc-157, tb-500, peptide, stack
Compounds in this protocol
How to read this protocol
The chart above shows the modeled blood concentration of each compound over the 8-week duration. Each compound accumulates toward steady state (roughly 5 half-lives). The peak-to-trough ratio within each dose interval depends on the injection frequency relative to the half-life.
Use the [peak-trough estimator](/tools/peak-trough) to see predicted levels at any point, or the [clearance calculator](/tools/clearance) to estimate washout after the protocol ends. The [PCT planner](/pct-planner) estimates when to start post-cycle therapy.
Educational only. Not medical advice. Concentration values are modeled estimates based on population pharmacokinetics, not predictions of individual blood levels.